Head-to-head · Cost-Efficiency Index
bmiMD vs Trimi Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
bmiMD
Price-driven shoppers who want both molecules cheap and nationwide, with a real month-to-month option if they don't want to prepay a year.
Visit bmiMDTrimi Health
Shoppers who can pay a full year up front, where the annual rate is genuinely among the cheapest all-50 tickets — and who will otherwise budget for the month-to-month rate.
Visit Trimi HealthThe verdict
bmiMD takes it, leading the Cost-Efficiency Index 82 to 78. Low $129/$179 month-to-month pricing on both molecules nationwide — the $99/$139 headline requires a full 12-month prepay, but a genuine no-commitment option still undercuts most of the ranking. Trimi Health still earns a C — Shoppers who can pay a full year up front, where the annual rate is genuinely among the cheapest all-50 tickets — and who will otherwise budget for the month-to-month rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs bmiMD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | bmiMD | Trimi Health |
|---|---|---|
| Cost-Efficiency Index | 82/100 | 78/100 |
| Semaglutide / mo | $129/mo (true month-to-month; $99/mo requires 12-mo prepay) | $175/mo month-to-month ($99/mo only on a 12-month prepay) |
| Tirzepatide / mo | $179/mo (true month-to-month; $139/mo requires 12-mo prepay) | $235/mo month-to-month ($125/mo only on a 12-month prepay) |
| Semaglutide / yr (modeled) | $1,548 | $2,100 |
| Tirzepatide / yr (modeled) | $2,148 | $2,820 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #24 | #30 |
bmiMD
82/100Where the value is
- Low prices on both molecules even month-to-month — $129 semaglutide / $179 tirzepatide, with no dose-based escalation
- A genuine no-commitment month-to-month option exists alongside the cheaper prepay tiers, unlike sites that gate pricing entirely behind a term
- Nationwide all-50 access with both molecules disclosed
The tradeoffs
- The advertised $99/$139 headline requires a full 12-month prepay ($1,188/$1,668 paid upfront) — the true month-to-month rate is 29-30% higher
- Compounded only — no oral or brand option
Trimi Health
78/100Where the value is
- Publishes every term rung openly — annual, six-month, quarterly and monthly are all priced on the page rather than revealed at checkout
- Price is flat at every dose, so titrating up does not raise the bill
- Both molecules available on one account, nationwide, with no enrollment or consultation fee
The tradeoffs
- The advertised $99 and $125 rates require a full year paid up front; month-to-month costs $175 and $235, a 77% and 88% premium
- No public LegitScript certification, so pharmacy oversight is harder to independently verify
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.